Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol

10 Moments That Changed HIV Care This Year

December 13, 2013

 5/12 

Long-Acting Antiretroviral Therapy Sensation

Long-Acting Antiretroviral Therapy Sensation

When once-a-day HIV medications became commonplace several years back, they revolutionized HIV treatment and helped make taking meds a much less intrusive part of people's daily lives.

Now just imagine what once-a-month HIV medications could do.

That pipe dream may not be so far from reality as it once seemed. This year, we learned much about a couple of "long-acting antiretroviral" candidates in the works. Most notable among these is GSK1265744 -- which, although it may need to be injected, is being engineered so that it only has to be taken once every four weeks at the most.

Early clinical trials involving these drugs have shown promising results. Now, to be sure, it's not a guarantee they'll work out, and many months of study lie ahead before we can even begin to entertain the idea that they'll become a part of regular HIV care. But it sure is an exciting concept to consider, all the more because it may be achievable.

Read the full story >>




Related Stories

2013 Year in Review: Features and News

This article was provided by TheBody.com.
 

Reader Comments:

Comment by: P. Kevin Parker (Cypress, CA) Sat., Feb. 15, 2014 at 6:53 am EST
The article summary states that testing patients only once a year for CD4 counts will save the medical industry $41,000 per patient. That's not what the original research said, according to the full article. The researcher calculated the medical savings of only one test per year in the 550 enrolled in the study's cohort. Not per patient.
Reply to this comment


Comment by: Reader (Chicago) Mon., Jan. 27, 2014 at 7:37 pm EST
The most important point of the "Baby Cure Commotion" should have been stated as the fact that the treatment guidelines were ignored.

What that tells us is that far too little effort/resources have been directed at very early treatment over the last two decade.

And where is the mention of the latest news that HIV is not directly killing CD4+ T cells?

That news tells us that far too little effort/resources have been directed at the pathogenesis of HIV/AIDS. The argument that "researchers were simply looking in the wrong place" (and missed the main pathogenic mechanism) is an excuse that begs for better over-sight of HIV/AIDS research in general.

Reply to this comment


Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement